Taysha Gene Therapies, Inc. (TSHA) — Cash & Equivalents
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $319.77M | +130.0% |
| 2024 | $139.04M | -3.4% |
| 2023 | $143.94M | +63.8% |
| 2022 | $87.88M | -41.1% |
| 2021 | $149.10M | -40.7% |
| 2020 | $251.25M | — |
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $319.77M | +130.0% |
| 2024 | $139.04M | -3.4% |
| 2023 | $143.94M | +63.8% |
| 2022 | $87.88M | -41.1% |
| 2021 | $149.10M | -40.7% |
| 2020 | $251.25M | — |